Novita Putri Rudiany
University of Groningen

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Private actor accountability on international regimes Wahyudi Purnomo; Novita Putri Rudiany; Citra Hennida
Masyarakat, Kebudayaan dan Politik Vol. 30 No. 4 (2017): Masyarakat, Kebudayaan dan Politik
Publisher : Faculty of Social and Political Science, Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (313.921 KB) | DOI: 10.20473/mkp.V30I42017.323-332

Abstract

Public-Private Partnerships (PPPs) have emerged along with the growing role of corporations in global development. One of the largest forms of PPP today is the UN Global Compact. The UN Global Compact involves of companies, NGOs, IGOs and state governments. All of them are trying to realize globalization with a more humanist face with attention to the protection of human rights, environment, labor standards and anti-corruption. Engaging private actors in global governance, The UN Global Compact raises many issues such as power, authority, and legitimacy. The effort to tackle it all is to increase PPP accountability. This research seeks to describe what efforts can be made to enhance private accountability within the international regime. The research undertaken is a descriptive study, focuses on public-private partnerships in the UN Global Compact regime. The study found that there were two attempts that could be done. First, by involving the stakeholders in the development of procedures, mechanisms, reporting and monitoring associated with trying to improve the company’s reputation. Second, by looking at corporate relations as agent and UN Global Compact as principal in principal-agent relation in the international regime.
Governing Global Health Care: A Case Study of India vis à vis Swirtzerland’s Novartis AG Regarding Patent of Gleevec Novita Putri Rudiany
Jurnal Hubungan Internasional Vol. 10 No. 1 (2017): Jurnal Hubungan Internasional
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (171.413 KB) | DOI: 10.20473/jhi.v10i1.3657

Abstract

India has been acknowledged as the pharmacy of the world because of its developed pharmaceutical industries which produce many kinds of medicine for any diseases. However, this condition does not make the government close the opportunities for foreign manufactures to sell their products for the citizens. One of the foreign industries is the Switzerland’s company, named Novartis AG, selling Gleevec, a leukemia-treating drug. In 2013, Novartis AG proposed to renew the patent of Gleevec because it has been updated from the last version of 1995, but Indian government rejected the patent rights of Gleevec based on the fact that the new Gleevec did not show any significant change for leukemia treatment. Based on the phenomenon, this paper examines about the dynamic of governing the global health with India as the case study. There are three perspectives that are used, those are: rejectionism, transnationalism and institutionalism. Each of the perspective focuses on the three discussions. It begins with the first part which explains the object that was being governed. The second part talks about the parties that have roles to govern. The third partelaborates on how those different parties governed the provision of the medicine production and distribution as the part of global health issue